We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

69 hedge funds and large institutions have $58.6M invested in Voyager Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 32 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $272K | Put options by funds: $116K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.51% less ownership

Funds ownership: 62.14% → 58.63% (-3.5%)

12% less funds holding

Funds holding: 78 → 69 (-9)

39% less capital invested

Capital invested by funds: $96.8M → $58.6M (-$38.2M)

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

50% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 32

Holders
69
Holders Change
-9
Holders Change %
-11.54%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
16
Reduced
32
Closed
17
Calls
$272K
Puts
$116K
Net Calls
+$156K
Net Calls Change
+$185K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$1.45M
2
EAM
Erste Asset Management
Austria
+$715K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$341K
4
FT
Fiduciary Trust
Massachusetts
+$303K
5
Belvedere Trading
Belvedere Trading
Illinois
+$204K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.03M
2
Millennium Management
Millennium Management
New York
-$794K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$687K
4
Charles Schwab
Charles Schwab
California
-$472K
5
JP Morgan Chase
JP Morgan Chase
New York
-$441K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$9K -$12.9K -3,961 -53%
QT
52
Quantbot Technologies
New York
$9K -$1.3K -400 -10%
HPC
53
HM Payson & Co
Maine
$7K – – –
SPIA
54
Steward Partners Investment Advisory
New York
$6K – – –
Citigroup
55
Citigroup
New York
$5K -$971 -299 -13%
ACM
56
Antonetti Capital Management
Florida
$4K +$4.87K +1,500 New
Fidelity Investments
57
Fidelity Investments
Massachusetts
$3K +$773 +238 +26%
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$2K -$17.2K -5,287 -89%
PCM
59
Penserra Capital Management
California
$2K +$32 +10 +1%
Simplex Trading
60
Simplex Trading
Illinois
$2K +$2.35K +724 New
PFGIA
61
Patriot Financial Group Insurance Agency
Massachusetts
$1K -$1.18K -364 -50%
WT
62
Washington Trust
Rhode Island
$1K – – –
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
$444 +$276 +85 +101%
Walleye Capital
64
Walleye Capital
New York
$42 +$52.2K +16,069 New
AQR Capital Management
65
AQR Capital Management
Connecticut
– -$687K -166,330 Closed
Charles Schwab
66
Charles Schwab
California
– -$472K -114,256 Closed
TEE
67
Tibra Equities Europe
United Kingdom
– -$314K -76,000 Closed
GPCM
68
Granite Point Capital Management
Massachusetts
– -$268K -65,000 Closed
ZCM
69
Zebra Capital Management
Connecticut
– -$220K -53,360 Closed
ECM
70
ExodusPoint Capital Management
New York
– -$146K -35,328 Closed
XT
71
XTX Topco
Cayman Islands
– -$138K -33,510 Closed
FWM
72
Focused Wealth Management
New York
– -$103K -25,000 Closed
Marshall Wace
73
Marshall Wace
United Kingdom
– -$90K -21,852 Closed
CIM
74
CIM Investment Management
Pennsylvania
– -$73K -17,691 Closed
LP
75
LMR Partners
United Kingdom
– -$70K -17,018 Closed
1 2
3
4

VYGR Hedge Fund Activity: Q3 2021 in Review

69 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2021, worth a combined $58.6M — down 39% from $96.8M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of VYGR and 9 opened new positions — a net loss of 8 holders — while 32 trimmed existing stakes and 16 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $1.45M. The largest seller was Citadel Advisors, cutting an estimated $2.03M.

  • 69 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2021, down from 78 in Q2 2021.
  • Funds reported $58.6M of Voyager Therapeutics stock for Q3 2021, down 39% quarter-over-quarter.
  • 9 funds opened new Voyager Therapeutics positions in Q3 2021 and 17 closed out, a net change of -8 holders.
  • The largest Voyager Therapeutics buyer in Q3 2021 was EcoR1 Capital, an estimated $1.45M added.
  • The largest Voyager Therapeutics seller in Q3 2021 was Citadel Advisors, an estimated $2.03M sold.

Based on aggregated 13F filings for Q3 2021.